Which Are the Major Opportunities in the Emerging Countries Which the Microreactor Technology Market Players Should Capitalize on for Revenue Benefits
A recent research study by Fact.MR finds that the microreactor sales reached 294 thousand units in 2018 and are projected to grow at a Y-O-Y of nearly 9% in 2019. Increasing competition among manufacturing companies in order to develop finer products remains a key aspect spurring the demand for microreactor technology. Ability of microreactor technology to facilitate effective and efficient drug synthesis is one of the key factors responsible for its rising adoption in the pharmaceutical industry.
View full press release